BIOMARIN PHARMACEUTICAL INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BIOMARIN PHARMACEUTICAL INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 0.00 shares, a 100.00% decline from fiscal 2024.
- BIOMARIN PHARMACEUTICAL INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 520.19K shares, a 37.90% decline from fiscal 2023.
- BIOMARIN PHARMACEUTICAL INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 837.62K shares, a 11.18% decline from fiscal 2022.
- BIOMARIN PHARMACEUTICAL INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 943.04K shares, a 5.62% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-12-31 | 0.00 shares 10-K · filed 2026-02-26 | |
| 2024-12-31 | 520.19K shares 10-K · filed 2025-02-24 | |
| 2023-12-31 | 837.62K shares 10-K · filed 2024-02-26 | |
| 2022-12-31 | 943.04K shares 10-K · filed 2023-02-27 | |
| 2021-12-31 | 892.89K shares 10-K · filed 2022-02-25 | |
| 2020-12-31 | 1.24M shares 10-K · filed 2021-02-26 | |
| 2019-12-31 | 567.67K shares 10-K · filed 2020-02-27 | |
| 2018-12-31 | 1.46M shares 10-K · filed 2019-02-28 | |
| 2017-12-31 | 1.37M shares 10-K · filed 2018-02-26 | |
| 2016-12-31 | 2.13M shares 10-K · filed 2017-02-27 | |
| 2015-12-31 | 1.72M shares 10-K · filed 2016-02-29 | |
| 2014-12-31 | 2.56M shares 10-K · filed 2015-03-02 | |
| 2013-12-31 | 2.89M shares 10-K · filed 2014-02-26 | |
| 2012-12-31 | 4.10M shares 10-K · filed 2013-02-26 | |
| 2011-12-31 | 1.92M shares 10-K · filed 2013-02-26 | |
| 2010-12-31 | 2.04M shares 10-K · filed 2013-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |